Skip to content

Effect of high-intensity functional training combined with selenium and zinc co-supplementation on sleep quality, functional capacity and weight loss in overweight and obese people

Effect of high-intensity functional training combined with selenium and zinc co-supplementation on sleep quality, functional capacity and weight loss in overweight and obese people: a randomized double-blind and placebo-controlled trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000042448
Enrollment
16
Registered
2025-01-20
Start date
2023-10-13
Completion date
2023-11-15
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Zinc (Zn) and selenium (Se) are trace elements that contribute to important biological processes in the human body. Cumulating research has demonstrated that obese people have lower Zn plasma levels compared with normal-weight people and that Se and Zn circulatory levels are inversely correlated with obesity and body fat mass. However, the evidence regarding the effects of the two micronutrients on body composition is conflicting. Furthermore, overweight and obese individuals are frequently characterized by reduced physical performance and disrupted thyroid function. This randomized double-blind and placebo-controlled trial examined the effects of Zn and Se co-supplementation on thyroid function, Zn and Se blood levels, resting metabolic rate, exercise performance, body composition, sleep quality, and quality of life in overweight and obese people undergoing diet and high-intensity functional training. Considering previous research indicating significant reductions in body weight and fat following a period of hypocaloric dieting combined with a HIFT program, we hypothesized that including Zn and Se supplements in this intervention would lead to even greater decreases in these parameters, and that would further improve functional capacity, resting metabolic rate, and sleep quality measures.

Interventions

Participants were randomly divided into two groups. Both groups underwent a 6-week intervention that included a hypocaloric diet and a high-intensity functional training program (HIFT). They differed based on whether they concurrently received one zinc and one selenium supplement or two placebos. The participants in the zinc-selenium co-supplementation group received a supplement containing 25 mg of zinc gluconate and another supplement containing 200 mcg of Se L-selenomethionine. After the base

Participants were randomly divided into two groups. Both groups underwent a 6-week intervention that included a hypocaloric diet and a high-intensity functional training program (HIFT). They differed based on whether they concurrently received one zinc and one selenium supplement or two placebos. The participants in the zinc-selenium co-supplementation group received a supplement containing 25 mg of zinc gluconate and another supplement containing 200 mcg of Se L-selenomethionine. After the baseline measurements, all participants were contacted by the research team's clinical dietician to create a custom-made diet plan. During the interview, participants provided information about their food preferences, allergies, and intolerances. A 24-hour dietary recall was used, with participants reporting their food and beverage intake in the 24-hour period before the interview. The diet plan covered the recommended dietary allowances, and the macronutrients distribution was 50% carbohydrates, 30% protein, and 20% fat. The total calories given to every participant were calculated considering the resting metabolic rate and the caloric expenditure of exercise and physical activity minus 500 calories to follow a hypocaloric diet. The participants of both groups participated in a group-based circuit-type HIFT two times/week and for six weeks. All classes were supervised by an experienced exercise scientist, and the number of participants in each class was small (8 people). Upon arrival at the gym’s facilities, participants performed a ten-minute warm-up using the three-phase RAMP method (Raise, Activate-Mobilize, Potentiate). Following the warm-up, participants completed the main protocol, which included 8-10 cardiometabolic, multi-joint resistance (upper-body; push and pull, lower-body knee-dominant; squat and lunge, hip-dominant; hinge and bridge, and core; plank movements) and neuromotor exercises (exercises aimed to improve balance, agility, coordination, reaction time, and proprioception), for 1-3 rounds. The appropriate exercise technique and baseline starting exercises for each participant were determined in a training session before the start of the intervention. At the end of every round, a rate of perceived exertion (RPE) measurement was conducted using the Borg RPE scale 6-20 to assess the level of exertion participants felt during the HIFT sessions. The mean RPE of each training day was also calculated. Furthermore, mean and maximum heart rates were monitored using Polar heart rate monitors (Polar® H7, Polar Electro Oy®, Kempele, Finland) for one session to measure exercise intensity objectively. The mean heart rate reverse of the participants was maintained higher 60% throughout each session. Progressive overload was achieved by decreasing the rest intervals or increasing the work intervals weekly and by increasing the number of exercises. When any of the exercises started to feel easier, the participants progressed to a harder variation. A 5-minute cool-down, including walking and static stretching exercises, was conducted at the end of the main training. The participants' adherence to the supplements was calculated using the number of remaining tablets at the end of the intervention. Adherence to the exercise program was determined by calculating the number of training days lost using a session attendance sheet. The data were analyzed only if compliance with the exercise program and supplement consumption was equal to or higher than 90%.

Sponsors

Christoforos Giannaki, University of Nicosia, Nicosia, Cyprus
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Inclusion criteria for the study were: (a) overweight or obese men and women (BMI > 25); (b) age 18–40 years; (c) no diet intervention during at least the last three months; and (d) no use of nutritional supplements/medications before (3 months) and during the study.

Exclusion criteria

Exclusion criteria were: (a) history of thyroid disease, positivity for thyroid autoanti-bodies, or treatment with medications potentially interfering with thyroid function; (b) diagnosis of cardiovascular, metabolic, pulmonary, renal, musculoskeletal, or mental disorders; and (c) pregnancy or lactation.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026